What is IPF Phase III Nintedanib (BIBF1120)?
CATEGORY:
TYPES:Generic: Nintedanib
This is a clinical trial studying the effectiveness and safety of Nintedanib, previously known as BIBF1120. Other names of the trial include NCT01335477, and INPULSIS-2.
Save up to 80% off your prescriptions!
How do members experience IPF Phase III Nintedanib (BIBF1120)?
Top 5 reported purposes & perceived effectiveness
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Idiopathic pulmonary fibrosis | 4 | 8 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Decreased appetite | 2 | |
| Abdominal pain | 1 | |
| Constipation | 1 | |
| Diarrhea | 1 | |
| Indigestion | 1 | |
| Metallic taste in mouth | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 2 | |
| Mild | 3 | |
| None | 2 |
Learn more about our community’s experience with IPF Phase III Nintedanib (BIBF1120)
What are people saying about IPF Phase III Nintedanib (BIBF1120)?
11
11
members have reported taking IPF Phase III Nintedanib (BIBF1120)
Join the conversation and connect with people who have taken IPF Phase III Nintedanib (BIBF1120)
Last updated: